[{"id":"b2a4ea25-8d18-422a-b5fb-b8838e229814","acronym":"","url":"https://clinicaltrials.gov/study/NCT05631912","created_at":"2022-11-30T17:57:35.016Z","updated_at":"2024-07-02T16:35:43.904Z","phase":"Phase 1/2","brief_title":"TRAC Locus-inserted CD19-targeting STAR-T Cell Therapy in r/r B-NHL","source_id_and_acronym":"NCT05631912","lead_sponsor":"Chinese PLA General Hospital","biomarkers":" BCL2 • CCND1 • BCL6 • IL6 • TNFA • IL2 • IL10","pipe":" | ","alterations":" CD19 positive • Chr t(11;14) • CCND1 overexpression • BCL6 rearrangement • Chr t(11;14)(q13;q32) • BCL2 rearrangement • CD20 negative","tags":["BCL2 • CCND1 • BCL6 • IL6 • TNFA • IL2 • IL10"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 positive • Chr t(11;14) • CCND1 overexpression • BCL6 rearrangement • Chr t(11;14)(q13;q32) • BCL2 rearrangement • CD20 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • autologous TRAC locus-inserted CD19-STAR-T"],"overall_status":"Recruiting","enrollment":" Enrollment 38","initiation":"Initiation: 06/30/2023","start_date":" 06/30/2023","primary_txt":" Primary completion: 12/15/2024","primary_completion_date":" 12/15/2024","study_txt":" Completion: 12/15/2025","study_completion_date":" 12/15/2025","last_update_posted":"2023-07-06"}]